The Sonic Hedgehog Pathway: An Unrealized Dream

Humans have three Hedgehog (Hh) genes: Sonic (SHH), Desert (DHH) and Indian (IHH). Of these three, Sonic Hedgehog is the most studied.

Update: July 1, 2022 —  A new study finds that a signaling molecule (SCUBE3) stimulates hair growth significantly. The hedgehog pathway is also involved.

Update: March 17, 2020 — A new study concluded that coordinated hedgehog signaling induces new hair follicle generation in adult skin. The activation of Hedgehog (Hh) signaling in adjacent epithelial and stromal cells in adult mice created de novo follicles.

Not surprisingly, the new hair follicles were also accompanied with skin tumors. However, treatment with Hedgehog-pathway inhibitor Vismodegib restricted tumor growth. At the same time, the new follicles remained intact.

This post was originally written in July 2017. Then updated in December 2018 with the latest major developments summarized at the bottom.

The Sonic Hedgehog Pathway and Hedgehog Signaling

Perhaps the most important area of hair loss research that I have not yet covered on this blog relates to the Sonic Hedgehog (SHH) protein and signaling pathway. This Shh pathway is used by cells to communicate with each other. While the sonic hedgehog protein has numerous critical effects on a developing human embryo (brain, craniofacial, lungs, teeth and more), it also continues to be important in adulthood when it controls certain stem cell division activities.

Getting into too much more detail about this would go beyond the scope of this blog. Shh was named after SEGA’s famous video game character, Sonic the Hedgehog.

Sato, Leopold and Crystal (1999)

In the initial decade after the first identification of the hedgehog gene around 1980, there was almost no research devoted to the impact of the SHH pathway upon human hair. However, this started to change in the mid-1990s (e.g., this from 1998).

It culminated in the seminal work on this subject that was published in the US in 1999: “Induction of the hair growth phase in postnatal mice by localized transient expression of Sonic hedgehog“.

Dr. Ronald Crystal: Sonic Hedgehog

Of the three authors of the above study, the most cited was Cornell based Dr. Ronald Crystal. He remains in practice even today.

These authors injecting balding mice hair cells with the sonic hedgehog gene using an adenovirus. They then discovered that resting hair follicles in the mice started growing robust hair of native hair color. They dyed all the existing fur blonde so as to differentiate it from the newly growing hair.

Moreover, upon final analysis, the team found that the SHH gene was active in the injected areas of the skin, but not elsewhere. A very humorous as well as highly informative article on this subject from 1999 can be read here.

Curis-Procter & Gamble Partnership RIP

After the groundbreaking 1999 study on mice, some researchers were mildly optimistic when it came androgenetic alopecia. They hoped that SHH activation could also have positive implications on human hair growth in balding men and women. A new company that was formed in 2000 called Curis partnered with Procter & Gamble in 2005. Their aim was to try and develop a topical Hedgehog agonist product for scalp hair growth.

However, this partnership ended in 2007 due to potential safety issues, since SHH can potentially also cause basal cell carcinoma cancer. P&G was not willing to continue with the drug development work. Even a very minimal risk of developing cancer is not worth it for treating cosmetic problems such as hair loss. At least in the eyes of government. Below is an interesting comment from the at-the-time CEO of Curis:

“We are obviously disappointed that the collaboration with Procter & Gamble will come to an end. We believe that our topically administered Hedgehog agonists have demonstrated encouraging efficacy in preclinical hair growth models and we were hopeful that one of our Hedgehog agonist drug candidates under the program would have progressed.”

Current Status

While the initial excitement of a SHH based cure for hair loss has long ended, sporadic research activity in this area continues (e.g, this in 2016). Moreover, in 2013, scientists even found that SHH signaling regenerates ear hair cells.

On a related note, read my post from earlier this year regarding ear hair regeneration and possible links with scalp hair regeneration. There is some controversy in that analogy if you read the comments to that post.

Hedgehog Pathway Update

On November 21st 2018, an important new study related to the Sonic Hedgehog (Shh) pathway and hair growth in mice was published in Nature Communications:

“Hedgehog stimulates hair follicle neogenesis by creating inductive dermis during murine skin wound healing.”

The lead author of this study is the famous Dr. Mayumi Ito, who I have covered numerous times on this blog. The research was led by Dr. Ito and her team from the NYU School of Medicine. Other well known co-authors include Dr. George Cotsarelis, Dr. Maksim Plikus and Dr. Sarah Millar.

For some reason, a number of newspapers around the world only covered these results a week after publication. Even Dr. Ito’s own university only discussed the findings on November 28th. More here.

The study authors claim to have shown that activation of the Sonic hedgehog (Shh) pathway regenerates dermal papilla cells. This in turn ensures hair follicle neogenesis. The experiment was done on wounded and damaged skin that was previously unable to grow hair.

Moreover, the authors have found a way to prevent cancerous tumor growth upon Shh pathway activation:

“To bypass the risk of tumors reported in other experiments that turned on the sonic hedgehog pathway, the NYU Langone team turned on only fibroblasts located just beneath the skin’s surface where hair follicle roots (dermal papillae) first appear.”

The study also has some very interesting discussion about the interplay with Shh signaling and Wnt signaling and activation.

Trinov Works Better in Women

I have discussed Trinov (formerly known as the Brotzu Lotion) a number of times on this blog. My main reason for doing so is because it is the first at least somewhat reputable new hair loss product that has been approved in many years.

Trinov is a non-prescription lotion that is is manufactured by well known Italian pharmaceutical company Fidia Farmaceutici. Trinov is currently sold by a number of Italian companies, and will be available for sale in the US in 2019.

Is Trinov going to bring back your childhood hairline? Not even close. Will it even bring back hair that you have lost more than several years ago? I highly doubt it, even if initial reports from a few years ago suggested that it could bring back hair that was lost up to five years ago.

However, I do believe in the science behind it, as I have stated a number of times before. I would not be surprised if Trinov ended up being at least as effective as Minoxidil.

Trinov
Trinov

Trinov consists of a three-pronged attack on hair loss via topical liposomal delivery of:

  1. Dihomo-γ-linolenic acid (DGLA), which improves microcirculation and blood and nutrient flow to the follicles.
  2. S-equol, which inhibits 5α-reductase enzyme activity. This reduces the conversion of testosterone into dihydrotestosterone (DHT).
  3. Propionyl-L-carnitine, which promotes lipid metabolism and stimulates energy production.

S-equol will obviously not inhibit DHT to the same extent as Dutasteride or Finasteride.

Trinov Works Better in Women than in Men

Dr. Giovanni Brotzu and various co-authors recently published a new study on Trinov. I am surprised that no-one on here or on the hair loss forums mentioned it, but there were some concrete findings in there. The most interesting ones:

  • Daily topical applications of the lotions resulted in a hair count that significantly increased for women and marginally increased for men after 6 months of treatment.
  • Significant increase in anagen hair and a significant decrease in telogen hair were observed starting from 3 months in male and 1 month in female patients.

So, in a rarity, women may benefit more from a hair loss treatment than men. As a male, I will still gladly take a cessation in hair loss and a marginal increase in new hair count if the above findings are really true.

It seems like there were two lotions in the study.

The male lotion was: TRINOV Lozione Anticaduta Uomo.

The female lotion was: TRINOV Lozione Anticaduta Donna.

Trinov E-Book

Several days ago commentator “Hope” posted a link to the new official Trinov website. You can read the Trinov e-book on there. Some highlights after translation:

The patented formula consists of phospholipid liposomes, i.e., microscopic vesicles formed by a double phospholipid state that protects the ingredients and allows controlled, local and gradual release, improving absorption in the application site.

After six months of daily application of TRINOV men’s anti-fall lotion the increase of total number of hair is observed in 63% of subjects treated; more than 70% perceive a minor fall, improve the condition of the scalp and report feeling healthier and stronger hair.

After 6 months of daily application of TRINOV Women Fallout Lotion the increase in the number total hair is observed in 90% of subjects treated; more than 70% report an improvement in the state of the scalp and refers to feel healthier and stronger hair, and almost 70% perceives one lower fall.

— Per part of the translation, it seems like Dr. Brotzu’s son Giovanni Brotzu is the CEO of the American company Liposome Advanced research LLC. Could not find much on the company in my few minutes of research.

— The first two new Trinov Youtube channel videos were not very encouraging.

Update: Fidia press release.

— Also see Trinov’s Facebook page.

My Thoughts on Trinov

Trinov will either be:

  • A new product that is similar to or slightly superior to Minoxidil. This would be miraculous, as only two products have ever been approved to treat hair loss (Minoxidil and Finasteride),

Or:

  • Yet another overblown overhyped hair loss product in a long list of them over the past few decades. This time, with the added insult (to us) and ignominy of being approved by a pharmaceutical company;  and of having famous doctors and universities involved in its research and development.